World Blood Screening Sector Discussed by M&M in New Research Study Published at MarketPublishers.com
20 Mar 2015 • by Natalie Aster
LONDON – Globally, the market for blood screening is poised for growth, expanding from a value of USD 1.5 billion as of 2014 to USD 2.55 billion by end-2019, recording around 10.5% CAGR. Grabbing the lion’s share of the total blood screening marketplace, the reagents segment will likely increase at the highest CAGR over the next five years. The segment is set to be primarily driven by the increasing volume of blood donations, reagents’ disposable nature, rising adoption of nucleic acid testing (NAT), and surging demand for blood for transfusion.
The growth in the overall blood screening market is inhibited by the mushrooming number of blood donors and donations, rising awareness concerning the safety of donated blood, growing patient affordability, the soaring demand for donated blood, and growing adoption of NAT by governments the world over. For example, in 2014, the Japanese Red Cross Society signed a 7-year agreement to utilise Grifols’ Procleix nucleic acid blood screening systems to screen Japan’s total blood supply for infectious diseases like Hepatitis and HIV.
New study “Blood Screening Market by Technology (Nucleic Acid Amplification Test, ELISA, Rapid Test, Chemiluminescence Immunoassay, Next Generation Sequencing, Western Blotting), Product (Instrument, Reagent) & End User (Blood Bank, Hospital) - Forecasts to 2019” сreated by MarketsandMarkets (M&M) examines the global blood screening market, segmented by services and products, technologies, end-user sectors, and regions. It presents accurate market data and qualitative information on the overall market and each individual segment covered. The report identifies the lucrative emerging markets, assesses the market for different blood screening products in various regions. Comprehensive insights on the upcoming technologies, R&D landscape, untapped regions, novel product and service launches in the blood screening sector, most recent developments and investments are provided. It also canvasses the market dynamics looking into the major restraints and drivers, challenges and opportunities. The research report profiles the top blood screening market players, giving information on their product portfolios, recent developments, and strategies adopted to maintain and boost their market shares in the short run. Granular market forecasts to 2019 are included as well.
Blood Screening Market by Technology (Nucleic Acid Amplification Test, ELISA, Rapid Test, Chemiluminescence Immunoassay, Next Generation Sequencing, Western Blotting), Product (Instrument, Reagent) & End User (Blood Bank, Hospital) - Forecasts to 2019
Published: March, 2015
Price: US$ 4,650.00
More new reports by the publisher can be found at MarketsandMarkets page.